Cannabinoids: possible role in patho‐physiology and therapy of Gilles de la Tourette syndrome

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Acta Psychiatrica Scandinavica

• Publication date

  1998-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0447.1998.tb10127.xPMID 9879795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoid/anandamide system and schizophrenia: is there evidence for association?

  1998cited by this paper
• 30 Years "Pharmacopsychiatry" - The journal and its Editor-in-Chief Bruno Müller-Oerlinghausen

  1998cited by this paper
• Evidence for a sex-specific residual effect of cannabis on visuospatial memory.

  1997cited by this paper
• Gilles de la Tourette - Syndrom - Eine aktuelle Übersicht

  1997cited by this paper
• Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding

  1996cited by this paper
• The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway.

  1995cited by this paper
• [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.

  1995cited by this paper
• Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats.

  1994cited by this paper
• Effective treatment of Tourette's syndrome with marijuana

  1993cited by this paper
• Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.

  1992cited by this paper
• Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

  1992cited by this paper
• Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons.

  1992cited by this paper
• Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment.

  1991cited by this paper
• Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons.

  1991cited by this paper
• The cannabinoid receptor: biochemical, anatomical and behavioral characterization.

  1990cited by this paper
• Cannabinoid receptor localization in brain.

  1990cited by this paper
• Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders.

  1989cited by this paper
• Marijuana and Tourette's syndrome.

  1988cited by this paper
• Health aspects of cannabis.

  1986cited by this paper
• Open label evaluation of cannabidiol in dystonic movement disorders.

  1986cited by this paper
• Disorders of movement

  1983cited by this paper
• Tetrahydrocannabinol for tremor in multiple sclerosis

  1983cited by this paper

• Premonitory urge in tic disorders – a scoping review

  2025cites this paper
• Long-term use of cannabis-based medicines in two children with Tourette syndrome: a case report

  2025cites this paper
• Editorial: Are we too high on medicinal cannabis in child psychiatry? Examining the evidence in Tourette syndrome.

  2025cites this paper
• Pharmacotherapy for Tourette Syndrome.

  2025cites this paper
• Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis

  2024cites this paper
• The Use of Cannabis-Based Medicine in Selected Neurological Disorders.

  2024cites this paper
• Pharmacological treatment of Tourette’s syndrome: from the past to the future

  2023cites this paper
• Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature

  2023cites this paper
• Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review

  2023cites this paper
• Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid- and steroid-based interventions

  2022cites this paper
• Die Bedeutung des Vorgefühls bei Tic-Störungen

  2022cites this paper
• Use of Medical Cannabis in Patients with Gilles de la Tourette's Syndrome in a Real-World Setting

  2022cites this paper
• A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome

  2022cites this paper
• INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE PATHOPHYSIOLOGY AND THERAPEUTICS OF MOVEMENT DISORDERS

  2022cites this paper
• Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study

  2022cites this paper
• Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study

  2021cites this paper
• Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study

  2021cites this paper
• Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.

  2021cites this paper
• A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette's Syndrome.

  2021cites this paper
• Cannabinoids in Neurologic Conditions

  2020cites this paper
• Medical Cannabis and Psychiatric Disorders: Implications for Psychiatric Nurses

  2020cites this paper
• Association of Tourette Syndrome and Chronic Tic Disorder With Subsequent Risk of Alcohol- or Drug-Related Disorders, Criminal Convictions, and Death: A Population-Based Family Study.

  2020cites this paper
• Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience.

  2020cites this paper
• Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature

  2020cites this paper
• Minimally Invasive Surgery for Chronic Pain Management: An Evidence-Based Approach

  2020cites this paper
• Medical and Surgical Treatments of Tourette Syndrome.

  2020cites this paper
• Behandlung des Tourette-Syndroms mit cannabisbasierten Medikamenten

  2020cites this paper
• Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome

  2020cites this paper
• Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome

  2020cites this paper
• Drug and Non-drug Treatment of Tourette Syndrome

  2020cites this paper
• Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination

  2019cites this paper
• Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey

  2019cites this paper
• Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.

  2019cites this paper
• Vaporized Cannabis Is Effective and Well-Tolerated in an Adolescent with Tourette Syndrome

  2019cites this paper
• Aripiprazole Selectively Reduces Motor Tics in a Young Animal Model for Tourette’s Syndrome and Comorbid Attention Deficit and Hyperactivity Disorder

  2018cites this paper
• Possible Role of the Endocannabinoid System in Tourette Syndrome

  2018cites this paper
• Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

  2017cites this paper
• Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

  2017cites this paper
• Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols

  2017cites this paper
• Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome.

  2017cites this paper
• [Gilles de la Tourette Syndrome: Symptoms, Causes and Therapy].

  2017cites this paper
• Cannabinoid-Based Medicines for the Treatment of Gilles de la Tourette Syndrome

  2017cites this paper
• Cannabinoids from Cannabis sp. : mechanism of their activity and potential health benefits in human body

  2017cites this paper
• Severe motor and vocal tics controlled with Sativex®

  2016cites this paper
• A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications.

  2016cites this paper
• Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy

  2016cites this paper
• Treatment-refractory Tourette Syndrome.

  2016influential citation
• A Comparison of Sativex ® and Aseco ® For Treatment of Severe Motor and Vocal Tics ; a Single Case Report

  2016cites this paper
• The therapeutic potential of cannabinoids for movement disorders

  2015cites this paper
• The endocannabinoid system and trichotillomania: A promising target for treatment?

  2015cites this paper
• Cannabinoids and the Tourette syndrome

  2015cites this paper
• Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

  2015cites this paper
• of Medicinal Marijuana , Cannabinoids , and Therapeutic Implications in Medicine and Headache : What a Long Strange Trip It ’ s

  2015cites this paper
• Cannabinoid-Based Drugs: Potential Applications in Addiction and Other Mental Disorders

  2015cites this paper
• Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics

  2015cites this paper
• Cannabinoids for epilepsy: is marijuana an effective treatment for epilepsy?

  2014cites this paper
• Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review

  2014cites this paper
• Cognoscenti of Cannabis I: Jacques-Joseph Moreau (1804-1884)

  2014cites this paper
• Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome.

  2013cites this paper
• Treatment of Tourette Syndrome with Cannabinoids

  2013cites this paper
• Pharmacological Options for the Treatment of Tourette’s Disorder

  2012cites this paper
• Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study

  2011influential citation
• Treatment strategies for tics in Tourette syndrome

  2011cites this paper
• Cannabinoids for Tourette's Syndrome (Review)

  2009cites this paper
• Tourette's syndrome.

  2009cites this paper
• Cannabinoids for Tourette's Syndrome.

  2009cites this paper
• Gilles de la Tourette Syndrome: symptomatic treatment based on evidence

  2009cites this paper
• Out of time? - Music, consciousness states and neuropharmacological mechanisms of an altered temporality

  2009cites this paper
• The influence of different food and drink on tics in Tourette syndrome

  2008cites this paper
• The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia

  2008cites this paper
• Cannabinoids in Tourette's syndrome

  2007cites this paper
• On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC)

  2007cites this paper
• The Future of Cannabinoids as Analgesic Agents: A Pharmacologic, Pharmacokinetic, and Pharmacodynamic Overview

  2007cites this paper
• A practical guide for clinicians

  2007cites this paper
• Tourette's syndrome and the law.

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper
• Le regard des sciences sociales

  2006cites this paper
• Cannabinoid control of motor function at the basal ganglia.

  2005cites this paper
• Endocannabinoids and Dopamine-Related Functions in the CNS

  2005cites this paper
• Therapeutic potential of the endocannabinoid system in the brain.

  2005cites this paper
• Cannabis et récepteurs cannabinoïdes: de la physiopathologie aux possibilités thérapeutiques.

  2004cites this paper
• [Cannabis and cannabinoid receptors: from pathophysiology to therapeutic options].

  2004cites this paper
• Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene

  2004influential citation
• CHRONIC CANNABIS USE AND ATTENTION- MODULATED PREPULSE INHIBITION OF THE STARTLE REFLEX IN HUMANS

  2004cites this paper
• Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Δ9-THC): No Influence on Neuropsychological Performance

  2003cites this paper
• [Therapeutic use of cannabinoids in neurology].

  2003cites this paper
• Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

  2003cites this paper
• Cannabinoids reduce symptoms of Tourette’s syndrome

  2003cites this paper
• Therapeutischer Einsatz von Cannabinoiden bei neurologischen Erkrankungen

  2003cites this paper
• Cannabis et neurologie

  2002cites this paper
• Endocannabinoids and basal ganglia functionality.

  2002cites this paper
• and Dopamine Receptor Antagonists

  2002cites this paper
• From cannabis to cannabinergics: new therapeutic opportunities.

  2002cites this paper
• Immunization with a cannabinoid receptor type 1 peptide results in experimental allergic meningocerebellitis in the Lewis rat: A model for cell‐mediated autoimmune neuropathology

  2002cites this paper
• The Medical use of Cannabis in Germany

  2002cites this paper
• The Role of Cannabis and Cannabinoids in Pain Management

  2002cites this paper
• The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

  2002cites this paper
• Combined Treatment of Tourette Syndrome with Δ9-THC and Dopamine Receptor Antagonists

  2002cites this paper
• Treatment of Tourette-Syndrome with ∆-Tetrahydrocannabinol (THC): a randomized crossover trial

  2002cites this paper
• Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.

  2002cites this paper